JAZZ

Jazz Pharmaceuticals plc

Nasdaq · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Jazz Pharmaceuticals develops and markets prescription medicines, with a focus on neuroscience treatments for sleep disorders like narcolepsy and idiopathic hypersomnia, as well as oncology drugs for cancers including leukemia and sarcoma.

Industry

Pharmaceutical Preparations

Headquarters

Dublin

Exchange

Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
COZADD BRUCE CDirector	Sell	$1.38M	6,000at $230.33	Oct 1, 2026
GALA RENEE DPresident & CEO	Sell	$486K	2,000at $243.03	Sep 8, 2026
Iannone RobertEVP, Global Head of R&D & CMO	Sell	$4.51M	18,187at $247.86	Aug 27, 2026
Iannone RobertEVP, Global Head of R&D & CMO	Sell	$2.84M	11,423at $248.67	Aug 27, 2026
Iannone RobertEVP, Global Head of R&D & CMO	Sell	$4.92M	19,639at $250.60	Aug 27, 2026
Iannone RobertEVP, Global Head of R&D & CMO	Sell	$76K	300at $252.76	Aug 27, 2026
Iannone RobertEVP, Global Head of R&D & CMO	Sell	$2.33M	9,259at $251.95	Aug 27, 2026
Iannone RobertEVP, Global Head of R&D & CMO	Sell	$4.53M	18,113at $250.02	Aug 27, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for JAZZ.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable JAZZ activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

Mobile number (optional)

SMS is optional: we only save your number if you check the consent box and provide a valid number. Outside US/Canada, include + and your country code.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.